Veritable’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-5,686
| Closed | -$203K | – | 336 |
|
|
2023
Q2 | $203K | Buy |
+5,686
| New | +$204K | ﹤0.01% | 849 |
|
|
2022
Q3 | – | Sell |
-19,585
| Closed | -$1.07M | – | 838 |
|
|
2022
Q2 | $1.07M | Buy |
19,585
+14,059
| +254% | +$776K | 0.02% | 359 |
|
|
2022
Q1 | $301K | Sell |
5,526
-26
| -0.5% | -$1.41K | ﹤0.01% | 719 |
|
|
2021
Q4 | $306K | Sell |
5,552
-74
| -1% | -$3.85K | ﹤0.01% | 710 |
|
|
2021
Q3 | $269K | Sell |
5,626
-1,396
| -20% | -$70.1K | ﹤0.01% | 735 |
|
|
2021
Q2 | $350K | Sell |
7,022
-383
| -5% | -$18.4K | 0.01% | 639 |
|
|
2021
Q1 | $330K | Buy |
7,405
+2,374
| +47% | +$108K | 0.01% | 626 |
|
|
2020
Q4 | $231K | Sell |
5,031
-1,289
| -20% | -$59.2K | ﹤0.01% | 716 |
|
|
2020
Q3 | $297K | Buy |
6,320
+2
| +0% | +$100 | 0.01% | 586 |
|
|
2020
Q2 | $322K | Buy |
6,318
+3
| +0% | +$154 | 0.01% | 581 |
|
|
2020
Q1 | $299K | Buy |
6,315
+52
| +0.8% | +$2.77K | 0.01% | 559 |
|
|
2019
Q4 | $368K | Sell |
6,263
-112
| -2% | -$6.23K | 0.01% | 601 |
|
|
2019
Q3 | $340K | Sell |
6,375
-420
| -6% | -$21.6K | 0.01% | 607 |
|
|
2019
Q2 | $340K | Buy |
6,795
+40
| +0.6% | +$2.01K | 0.01% | 613 |
|
|
2019
Q1 | $353K | Buy |
6,755
+1,022
| +18% | +$51.1K | 0.01% | 597 |
|
|
2018
Q4 | $274K | Sell |
5,733
-837
| -13% | -$41.2K | 0.01% | 627 |
|
|
2018
Q3 | $330K | Buy |
6,570
+1,156
| +21% | +$58.7K | 0.01% | 615 |
|
|
2018
Q2 | $273K | Sell |
5,414
-16
| -0.3% | -$806 | 0.01% | 673 |
|
|
2018
Q1 | $265K | Buy |
+5,430
| New | +$253K | 0.01% | 671 |
|
|
2017
Q4 | – | Sell |
-5,002
| Closed | -$254K | – | 824 |
|
|
2017
Q3 | $254K | Sell |
5,002
-1,491
| -23% | -$75.6K | 0.01% | 660 |
|
|
2017
Q2 | $350K | Buy |
6,493
+372
| +6% | +$19.8K | 0.01% | 590 |
|
|
2017
Q1 | $323K | Buy |
6,121
+592
| +11% | +$30K | 0.01% | 585 |
|
|
2016
Q4 | $266K | Buy |
5,529
+997
| +22% | +$49.3K | 0.01% | 623 |
|
|
2016
Q3 | $244K | Sell |
4,532
-27
| -0.6% | -$1.48K | 0.01% | 643 |
|
|
2016
Q2 | $247K | Buy |
4,559
+81
| +2% | +$4.27K | 0.01% | 615 |
|
|
2016
Q1 | $227K | Sell |
4,478
-2,723
| -38% | -$136K | 0.01% | 633 |
|
|
2015
Q4 | $363K | Buy |
7,201
+2,376
| +49% | +$121K | 0.01% | 550 |
|
|
2015
Q3 | $232K | Buy |
4,825
+39
| +0.8% | +$2.03K | 0.01% | 630 |
|
|
2015
Q2 | $249K | Sell |
4,786
-4,564
| -49% | -$257K | 0.01% | 633 |
|
|
2015
Q1 | $539K | Buy |
9,350
+1,049
| +13% | +$60.1K | 0.01% | 585 |
|
|
2014
Q4 | $443K | Sell |
8,301
-10,607
| -56% | -$593K | 0.01% | 633 |
|
|
2014
Q3 | $1.09M | Sell |
18,908
-2,402
| -11% | -$147K | 0.02% | 382 |
|
|
2014
Q2 | $1.43M | Buy |
21,310
+799
| +4% | +$54.1K | 0.03% | 324 |
|
|
2014
Q1 | $1.37M | Sell |
20,511
-5,315
| -21% | -$359K | 0.03% | 324 |
|
|
2013
Q4 | $1.72M | Sell |
25,826
-3,875
| -13% | -$251K | 0.04% | 272 |
|
|
2013
Q3 | $1.86M | Buy |
29,701
+10,610
| +56% | +$683K | 0.04% | 255 |
|
|
2013
Q2 | $1.19M | Buy |
+19,091
| New | +$1.21M | 0.03% | 351 |
|
Other funds holding GSK
JEST
